Tumour suppressor TRIM33 targets nuclear β-catenin degradation

Nature Communications

Volumn 6, Issue , 2015, Pages

  Xue, Jianfei ^a   Chen, Yaohui ^a   Wu, Yamei ^a   Wang, Zhongyong ^a   Zhou, Aidong ^a   Zhang, Sicong ^a,b   Lin, Kangyu ^a   Aldape, Kenneth ^a   Majumder, Sadhan ^a,b   Lu, Zhimin ^a,b   Huang, Suyun ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; GLYCOGEN SYNTHASE KINASE 3BETA; PROTEIN KINASE C DELTA; SERINE; TRIPARTITE MOTIF CONTAINING PROTEIN 33; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; TRANSCRIPTION FACTOR; TRIM33 PROTEIN, HUMAN;

BRAIN; CANCER; CYTOLOGY; DEGRADATION; ENZYME ACTIVITY; PROTEIN; TUMOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN TISSUE; BRAIN TUMOR; CANCER INHIBITION; CARCINOGENESIS; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; TUMOR CELL; UBIQUITINATION; ANIMAL; CELL LINE; GENETICS; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ANIMALS; BETA CATENIN; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; MICE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; UBIQUITINATION;

EID: 84923070705     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms7156     Document Type: Article

References (41)

1. Valenta, T., Hausmann, G. & Basler, K. The many faces and functions of b-catenin. EMBO J. 31, 2714-2736 (2012).
2. Kim, S. E. et al. Wnt stabilization of b-catenin reveals principles for morphogen receptor-scaffold assemblies. Science 340, 867-870 (2013).
3. MacDonald, B. T., Tamai, K. & He, X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev. Cell 17, 9-26 (2009).
4. Clevers, H. & Nusse, R. Wnt/b-catenin signaling and disease. Cell 149, 1192-1205 (2012).
5. Yang, W. et al. Nuclear PKM2 regulates b-catenin transactivation upon EGFR activation. Nature 480, 118-122 (2011).
6. Lu, Z. & Hunter, T. Wnt-independent beta-catenin transactivation in tumor development. Cell Cycle 3, 571-573 (2004).
7. Hölsken, A. EGFR signaling regulates tumor cell migration in craniopharyngiomas. Clin. Cancer Res. 17, 4367-4377 (2011).
8. Anastas, J. N. & Moon, R. T. WNT signalling pathways as therapeutic targets in cancer. Nat. Rev. Cancer 13, 11-26 (2013).
9. Chitalia, V. et al. c-Cbl, a ubiquitin E3 ligase that targets active b-catenin: a novel layer of Wnt signaling regulation. J. Biol. Chem. 288, 23505-23517 (2013).
10. Hatakeyama, S. TRIM proteins and cancer. Nat. Rev. Cancer 11, 792-804 (2011).
11. Ransom, D. G. et al. The zebrafish moonshine gene encodes transcriptional intermediary factor 1gamma, an essential regulator of hematopoiesis. PLoS Biol 2, E237 (2004).
12. Kulkarni, A. et al. Tripartite Motif-containing 33 (TRIM33) protein functions in the poly (ADP-ribose) polymerase (PARP)-dependent DNA damage response through interaction with Amplified in Liver Cancer 1 (ALC1) protein. J. Biol. Chem. 288, 32357-32369 (2013).
13. Sedgwick, G. G. et al. Transcriptional intermediary factor 1g binds to the anaphase-promoting complex/cyclosome and promotes mitosis. Oncogene 32, 4622-4633 (2013).
14. Bai, X. et al. TIF1gamma controls erythroid cell fate by regulating transcription elongation. Cell 142, 133-143 (2010).
15. Aucagne, R. et al. Transcription intermediary factor 1g is a tumor suppressor in mouse and human chronic myelomonocytic leukemia. J. Clin. Invest. 121, 2361-2370 (2011).
16. He, W. et al. Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway. Cell 125, 929-941 (2006).
17. Dupont, S. et al. FAM/USP9x, a deubiquitinating enzyme essential for TGFbeta signaling, controls Smad4 monoubiquitination. Cell 136, 123-135 (2009).
18. Herquel, B. et al. Transcription cofactors TRIM24, TRIM28, and TRIM33 associate to form regulatory complexes that suppress murine hepatocellular carcinoma. Proc. Natl Acad. Sci. USA 108, 8212-8217 (2011).
19. Vincent, D. F. et al. Inactivation of TIF1gamma cooperates with Kras to induce cystic tumors of the pancreas. PLoS Genet. 5, e1000575 (2009).
20. Vincent, D. F. et al. Tif1g suppresses murine pancreatic tumoral transformation by a Smad4-independent pathway. Am. J. Pathol. 180, 2214-2221 (2012).
21. Kolligs, F. T., Hu, G., Dang, C. V. & Fearon, E. R. Neoplastic transformation of RK3E by mutant beta-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression. Mol. Cell. Biol. 19, 5696-5706 (1999).
22. Liu, C. et al. beta-Trcp couples beta-catenin phosphorylation-degradation and regulates Xenopus axis formation. Proc. Natl Acad. Sci. USA 96, 6273-6278 (1999).
23. Nathan, J. A., Kim, H. T., Ting, L., Gygi, S. P. & Goldberg, A. L. Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? EMBO J. 32, 552-565 (2013).
24. Liu, C. et al. Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 108, 837-847 (2002).
25. Van Noort, M., Meeldijk, J., van der Zee, R., Destree, O. & Clevers, H. Wnt signaling controls the phosphorylation status of beta-catenin. J. Biol. Chem. 277, 17901-17905 (2002).
26. Metzger, T., Kleiss, C. & Sumara, I. CUL3 and protein kinases: insights from PLK1/KLHL22 interaction. Cell Cycle 12, 2291-2296 (2013).
27. Winston, J. T. et al. The SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitro. Genes Dev. 13, 270-283 (1999).
28. Liu, J. et al. Siah-1 mediates a novel beta-catenin degradation pathway linking p53 to the adenomatous polyposis coli protein. Mol. Cell 7, 927-936 (2001).
29. Chitalia, V. C. et al. Jade-1 inhibits Wnt signalling by ubiquitylating beta-catenin and mediates Wnt pathway inhibition by pVHL. Nat. Cell Biol. 10, 1208-1216 (2008).
30. Cerda, S. R. et al. Protein kinase C delta inhibits Caco-2 cell proliferation by selective changes in cell cycle and cell death regulators. Oncogene 25, 3123-3138 (2006).
31. Perletti, G. P., Marras, E., Concari, P., Piccinini, F. & Tashjian, Jr A. H. PKCdelta acts as a growth and tumor suppressor in rat colonic epithelial cells. Oncogene 18, 1251-1256 (1999).
32. Aberle, H., Bauer, A., Stappert, J., Kispert, A. & Kemler, R. beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J. 16, 3797-3804 (1997).
33. Wu, X. et al. Rac1 activation controls nuclear localization of beta-catenin during canonical Wnt signaling. Cell 133, 340-353 (2008).
34. Song, D. H. et al. CK2 phosphorylation of the armadillo repeat region of beta-catenin potentiates Wnt signaling. J. Biol. Chem. 278, 24018-24025 (2003).
35. Fang, D. et al. Phosphorylation of beta-catenin by AKT promotes beta-catenin transcriptional activity. J. Biol. Chem. 282, 11221-11229 (2007).
36. Zhu, G. et al. A Rac1/PAK1 cascade controls b-catenin activation in colon cancer cells. Oncogene 31, 1001-1012 (2012).
37. Hernández-Maqueda, J. G., Luna-Ulloa, L. B., Santoyo-Ramos, P., Castañeda-Patlán, M. C. & Robles-Flores, M. Protein kinase C delta negatively modulates canonical Wnt pathway and cell proliferation in colon tumor cell lines. PLoS ONE 8, e58540 (2013).
38. Xue, J. et al. Sustained activation of SMAD3/SMAD4 by FOXM1 promotes TGF-b-dependent cancer metastasis. J. Clin. Invest. 124, 564-579 (2014).
39. Thakur, R. & Mishra, D. P. Pharmacological modulation of beta-catenin and its applications in cancer therapy. J. Cell. Mol. Med. 17, 449-456 (2013).
40. Zhang, N. et al. FoxM1 promotes beta-cateninnuclear localization and controls Wnt target-geneexpression and glioma tumorigenesis. Cancer Cell 20, 427-442 (2011).
41. Huang, F. J. et al. Molecular basis for the critical role of suppressor of cytokine signaling-1 in melanoma brain metastasis. Cancer Res. 68, 9634-9642 (2008).